Parkwood LLC’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-72,785
| Closed | -$25.5M | – | 90 |
|
|
2025
Q4 | $25.5M | Buy |
72,785
+18,733
| +35% | +$6.33M | 1.98% | 12 |
|
|
2025
Q3 | $17.5M | Sell |
54,052
-5,959
| -10% | -$1.85M | 1.59% | 15 |
|
|
2025
Q2 | $23.3M | Buy |
60,011
+9,357
| +18% | +$3.76M | 2.09% | 7 |
|
|
2025
Q1 | $22M | Buy |
50,654
+201
| +0.4% | +$80.7K | 2.03% | 14 |
|
|
2024
Q4 | $18.6M | Buy |
50,453
+2,357
| +5% | +$986K | 2.12% | 7 |
|
|
2024
Q3 | $25M | Buy |
48,096
+3,129
| +7% | +$1.67M | 1.76% | 10 |
|
|
2024
Q2 | $24.4M | Buy |
44,967
+5,586
| +14% | +$2.95M | 3.03% | 5 |
|
|
2024
Q1 | $20.4M | Buy |
39,381
+3,180
| +9% | +$1.58M | 1.84% | 8 |
|
|
2023
Q4 | $17.1M | Buy |
36,201
+6,920
| +24% | +$3.2M | 2.04% | 11 |
|
|
2023
Q3 | $12.8M | Sell |
29,281
-5,759
| -16% | -$2.61M | 1.38% | 11 |
|
|
2023
Q2 | $15.6M | Buy |
35,040
+4,278
| +14% | +$1.97M | 2.83% | 4 |
|
|
2023
Q1 | $14.1M | Sell |
30,762
-5,716
| -16% | -$2.72M | 1.94% | 11 |
|
|
2022
Q4 | $18.7M | Sell |
36,478
-1,731
| -5% | -$879K | 2.84% | 5 |
|
|
2022
Q3 | $17.4M | Buy |
38,209
+5,389
| +16% | +$2.58M | 2.63% | 6 |
|
|
2022
Q2 | $15.8M | Sell |
32,820
-4,074
| -11% | -$2.02M | 2.82% | 3 |
|
|
2022
Q1 | $18.1M | Buy |
36,894
+3,769
| +11% | +$1.72M | 2.97% | 4 |
|
|
2021
Q4 | $15.4M | Buy |
33,125
+2,015
| +6% | +$848K | 2.62% | 4 |
|
|
2021
Q3 | $11.6M | Buy |
31,110
+2,422
| +8% | +$920K | 1.4% | 10 |
|
|
2021
Q2 | $11M | Sell |
28,688
-1,671
| -6% | -$639K | 1.27% | 10 |
|
|
2021
Q1 | $10.9M | Buy |
30,359
+4,432
| +17% | +$1.43M | 1.93% | 10 |
|
|
2020
Q4 | $8.32M | Sell |
25,927
-2,231
| -8% | -$685K | 1.01% | 21 |
|
|
2020
Q3 | $7.56M | Sell |
28,158
-48
| -0.2% | -$12.9K | 1.16% | 18 |
|
|
2020
Q2 | $7.42M | Sell |
28,206
-13,014
| -32% | -$3.47M | 1.33% | 19 |
|
|
2020
Q1 | $9.36M | Buy |
41,220
+2,811
| +7% | +$766K | 1.9% | 11 |
|
|
2019
Q4 | $11.6M | Buy |
38,409
+10,333
| +37% | +$2.84M | 2.43% | 7 |
|
|
2019
Q3 | $6.74M | Sell |
28,076
-33,044
| -54% | -$9.05M | 1.36% | 16 |
|
|
2019
Q2 | $17.2M | Buy |
61,120
+9,643
| +19% | +$2.63M | 3.68% | 3 |
|
|
2019
Q1 | $14.8M | Buy |
51,477
+2,304
| +5% | +$666K | 2.89% | 7 |
|
|
2018
Q4 | $12.9M | Buy |
49,173
+18,206
| +59% | +$5.01M | 2.96% | 6 |
|
|
2018
Q3 | $8.49M | Buy |
30,967
+5,252
| +20% | +$1.36M | 1.44% | 18 |
|
|
2018
Q2 | $6.12M | Sell |
25,715
-27,604
| -52% | -$6.39M | 0.96% | 26 |
|
|
2018
Q1 | $11.7M | Buy |
53,319
+28,702
| +117% | +$6.74M | 1.67% | 11 |
|
|
2017
Q4 | $5.54M | Buy |
24,617
+20,221
| +460% | +$4.31M | 0.75% | 34 |
|
|
2017
Q3 | $835K | Sell |
4,396
-18,476
| -81% | -$3.52M | 0.12% | 92 |
|
|
2017
Q2 | $4.3M | Sell |
22,872
-2,341
| -9% | -$421K | 0.65% | 42 |
|
|
2017
Q1 | $4.17M | Buy |
25,213
+4,908
| +24% | +$781K | 0.59% | 42 |
|
|
2016
Q4 | $2.92M | Buy |
+20,305
| New | +$2.72M | 0.45% | 57 |
|
|
2016
Q2 | – | Sell |
-15,346
| Closed | -$2.13M | – | 455 |
|
|
2016
Q1 | $2.13M | Sell |
15,346
-9,642
| -39% | -$1.29M | 0.36% | 62 |
|
|
2015
Q4 | $3.48M | Buy |
24,988
+20,222
| +424% | +$2.79M | 0.55% | 40 |
|
|
2015
Q3 | $667K | Sell |
4,766
-325
| -6% | -$48.8K | 0.11% | 106 |
|
|
2015
Q2 | $836K | Buy |
5,091
+13
| +0.3% | +$2.08K | 0.12% | 88 |
|
|
2015
Q1 | $784K | Buy |
5,078
+15
| +0.3% | +$2.14K | 0.1% | 98 |
|
|
2014
Q4 | $636K | Buy |
5,063
+1,577
| +45% | +$195K | 0.09% | 131 |
|
|
2014
Q3 | $417K | Buy |
3,486
+1,355
| +64% | +$155K | 0.09% | 117 |
|
|
2014
Q2 | $229K | Buy |
+2,131
| New | +$220K | 0.05% | 120 |
|
|
2014
Q1 | – | Sell |
-1,614
| Closed | -$149K | – | 247 |
|
|
2013
Q4 | $149K | Buy |
+1,614
| New | +$143K | 0.04% | 304 |
|
Other funds holding ELV
Parkwood LLC's ELV Position: Q1 2026 in Review
Parkwood LLC sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 72,785 shares — an estimated $25.5M sold.
Parkwood LLC first reported a position in ELV in Q4 2013 and held it in 46 quarters. The position peaked at $25.5M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Parkwood LLC reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Parkwood LLC sold 72,785 Elevance Health shares in Q1 2026, an estimated $25.5M.
- Parkwood LLC first reported a position in Elevance Health in Q4 2013 and held it in 46 quarters.
- Parkwood LLC's Elevance Health position peaked at $25.5M in Q4 2025.
- 1,470 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Parkwood LLC's 13F filing for Q1 2026, filed 15 May 2026.